Monday, 23 Dec 2024

Bid to find first effective HIV vaccine launched by British researchers

A CLINICAL trial for an HIV vaccine has been launched by British researchers.

The test aims to evaluate its safety, tolerability and ability to prime the immune system.


Thirteen healthy HIV-negative adults, aged 18 to 65, will receive one dose of the jab and then a booster after four weeks.

University of Oxford experts are testing HIVconsvX — a mosaic vaccine which combines a range of HIV variants that makes it potentially applicable to all global strains.

Unlike most HIV jab candidates, it induces T cells rather than B cells.

Lead researcher Tomáš Hanke is a professor of vaccine immunology at the Jenner Institute, University of Oxford.

Most read in Health News

EXTRA ZEST

Combining lime with Viagra makes drug up to four times more potent

jab happy

Major change to Covid booster jabs from Monday as PM set to ease restrictions

PAY UP

NHS rule change could see MILLIONS charged for prescriptions they now get for free

Safety FIRST

Find out how long after booster jab you get an accurate lateral flow result

He said: “An effective HIV vaccine has been elusive for 40 years.

“This trial is the first in a series of evaluations of this novel vaccine strategy in HIV-negative individuals for prevention and in people living with HIV for cure.”

The researchers hope to report on the results of the trial by next April.

    Source: Read Full Article

    Related Posts